Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The EMEA region is witnessing a significant increase in the aging population, contributing to a higher prevalence of orthopedic disorders such as osteoarthritis and fractures. This demographic shift is a major driver for the orthopedic biomaterial market, as the elderly demographic requires advanced orthopedic solutions.
A significant development in biomaterials such as ceramics, metals, polymers and also the biologics is redesigning the orthopedic biomaterial market of EMEA region. New materials which are advanced in biocompatibility and corrosion resistance properties will have a leading role, giving rise to improved orthopedic implants and devices.
The growing incidence of disorders related to the joints has led to a widespread need for surgery involving replacement among individuals in the EMEA region. Biomaterials play an important role in these operations as materials such as titanium alloys and ceramic implants are widely used for hip or knee replacements which change dynamics of the market positively.
A growing trend in the EMEA region is minimally invasive orthopedic procedures thus, developments and adoption of biomaterials appropriate for these operations. More and more biomaterials that encourage minimally invasive procedures, shortening recovery period as well as limiting postoperative complications are getting popular in the market.
Stringent regulatory standard in Europe and other regions of the EMEA area are affecting orthopedic biomaterial market. Sticking to standards dictated by applicable regulatory bodies including European Medicines Agency (EMA) and national health authorities is highly important for gaining approval of the product on markets.
The recognition of biocompatible materials and their significance among the healthcare professionals as well as patients is increasing. It is the preference for materials that blend into the natural functioning of body and enhance longevity in implanting orthopedic biomaterials, this trend characterizes dynamics of market.
The firms involved in the EMEA orthopedic biomaterial market are augmenting their investments on research and development activities. Such focus is aimed at innovating R&D to introduce new biomaterials, enhance currently existing technologies and meet unmet needs in the orthopedic treatment field enabling innovation on the market.
Trauma cases such as fractures among other injury related to sports are fueling the need for orthopedic biomaterials. Biomaterials that promote bone healing and regeneration play a significant role in trauma which is also one of the key drivers influencing market dynamics for orthopedic surgeons to find advanced solutions for better patient results.
Competitiveness regarding the key players is found in EMEA orthopedic biomaterial market. Strategic alliances, partnerships as well mergers and acquisitions are some of the common strategies used by companies in order to strengthen their market presence, widen product portfolios among others.
Ongoing developments in healthcare infrastructure across the EMEA region are influencing the orthopedic biomaterial market. The expansion of healthcare facilities and the incorporation of advanced technologies create a conducive environment for the adoption of innovative orthopedic biomaterials.
Europe Orthopedic Biomaterial Market Highlights:
Europe, Middle East and Africa Orthopedic Biomaterial Market Overview
Europe Orthopedic Biomaterial Market Size was valued at USD 8.24 Billion in 2023. The Global Europe Orthopedic Biomaterial industry is projected to grow from USD 9.30 Billion in 2024 to USD 24.57 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.08% during the forecast period (2024 - 2032). Biomaterial is acquiring a huge demand for the treatment of different diseases and condition. They have got a special attention in the orthopedic segment. Many different type of implant are prepare by using biomedical.
Increasing aging population is the major driver for the growth of orthopedic market in Europe Middle East and Africa. As this material did not cause any immunological reaction with the body, this makes it as a first choice of preference for manufacturing of the implants. Due to lack of exercise the many different bones and muscle related complication are occurred. This led to increase in the market of orthopedic biomedical in Europe and Middle East and Africa.
Study Objectives of Europe, Middle East and Africa Orthopedic Biomaterial Market information:
- This report gives the complete detail analysis of competitive dynamics.
- To provide the detail information about drivers and factors restraining the market growth.
- Detail information about current opportunities and trend in the market.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to three main geographies and their countries.
- To provide the overview of key players and their strategic profiles in the market and drawing a competitive landscape for the market.
- To provide the market growth map over the forecasted period- 2017-2023.
- To provide the graphs and analyze the market on various factors like- price analysis, supply chain analysis, porters five force analysis etc.
Key Players for Orthopedic Biomaterials Market
Some of the major players in this market are:
- Materion Corporation (US)
- S&V Technologies (Germany)
- Rayner (UK)
- InVision Biomedical (US)
- Royal DSM (Netherlands)
- BASF SE (Germany)
- Carpenter Technology Corporation (US)
- Covestro (Germany)
- Invibio Ltd. (U.K.)
- Ulbrich Stainless Steel & Special Metals, Inc. (US)
- Corbion N.V. (Netherlands)
- CeramTec (Germany)
- Ceradyne (US)
- Heraeus Medical Components (US)
- Kyocera Corporation (Japan)
- Ticona GmbH (Germany)
- Johnson & Johnson (US)
- Osteotech, Inc. (US)
- Cam Bioceramics B.V. (Netherland)
- Evonik Industries AG (Germany)
Orthopedic Biomaterials Market Segmentation
Orthopedic Biomaterials Market is segmented on the basis of, by type of material which is Metals and Non-metals. Metals are further sub segmented into stainless steel, Titanium Alloy, Cobalt alloy and others. Non Metal is sub segmented into Ceramic (Alumina, Calcium Phosphate, Zirconium dioxide. Carbon and Other), Polymeric (Polymethylmethacrylate, Polyethylene, Silicone, Polyester and Other), Natural Biomaterials (Collagen, Chitin & Chitosan and Other) and Others.
On the Basis of application the market is segmented into Joint Replacement, fracture Fixation Devices, Tissue Fixation, Spine implants, Viscosupplementation and Other. Joint replacement is sub segmented into Hip replacement, Knee replacement, Shoulder and elbow replacement and other. Tissue fixation is sub segmented into interference screws, suture anchors and others. Spine implants is further sub segmented into spine fusion, other. Fracture Fixation Devices are sub segmented into Screws, Plates for Bones, Rods and other.
Orthopedic Biomaterials Market Regional Analysis
Europe and Middle East and Africa are the two major region of the market. Europe has the second largest market for orthopedic biomedical globally. Patient with high level of pain in the bones has no option other than joint replacement which improves the quality of life. Germany and UK are invest ample amount of capital in import of the implants. This can serves as an opportunities for the manufacturer to develop the market in this countries. Due to limited infrastructure development Middle East and Africa has a least orthopedic biomedical market.
Market Assessment
The report for Europe, Middle East and Africa Orthopedic Biomaterial Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Intended Audience
- Product manufacturers
- Biomaterial manufacturer
- Research and Development (R&D) Companies
- Hospitals and Laboratories
- Suppliers and distributor of biomaterial.
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
